The Hindu Business Line : Zydus Cadila launches 43 drugs in French market

THE Ahmedabad-based generics major Zydus Cadila has launched 43 drugs in the French market and announced that it would launch another 20 products by December.

The products that were launched on Thursday were in six broad therapeutic categories - cardiovasculars, central nervous system (CNS), gastrointestinals, pain management, Type-II diabetes and anti-infectives, a company release said here.

"As part of its plan to aggressively promote generics, the group will be strengthening its presence with 20 more products by December 2004, taking the total number of the generics marketed by Zydus France to 63. By 2006, the group is likely to launch 25 more products, which would be going off patent," the release said.

Zydus Cadila entered the French market with the acquisition of Alpharma France in 2003. The company, with its ready distribution channel and a pipeline of 109 generics registrations, is being used by the Indian company to tap the French market, pegged at $1.25 billion and growing at 30 per cent annually, it said.

"We aim to capture 1-3 per cent of the market-share in various product categories by the end of 2006. In the first phase, we are focusing our efforts on positioning Zydus France as a company that looks beyond drug dispensing. We would work closely with the community and pharmacists to create a strong product line," the release quoted Mr David Blanksby, Vice-President and Managing Director (Europe), as saying.

More Stories on : Announcements | New Products & Services | Pharmaceuticals

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page